Medicine: papers

Sign in Get started

Filters2 filters applied

Status

Corrected
No notice
Not checked
From publisher notices and Retraction Watch. Not checked means nobody has looked yet.

Year

Readable here

Study type

Randomised trial

Licence

5 papers4 with full text Questions on this topic

1 filter appliedStatus: Corrected Clear all

Corrected
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M Folegatti, Mustapha Bittaye, Amy Flaxman et al. · The Lancet Infectious Diseases · 2020
Abstract only
Corrected
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study
Timothy M Walker, Matthias Merker, Astrid M Knoblauch et al. · The Lancet Infectious Diseases · 2018
Full textCC BY
Corrected
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin, Jeannie Callum, Erin Jamula et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Corrected
IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
Lenette L. Lu, Malisa T. Smith, Krystle K. Q. Yu et al. · Nature Medicine · 2019
Full textCC BY
Corrected
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch et al. · PLoS Medicine · 2010 · Randomised trial
Full textCC0